Improved heart rate variability signal analysis from the beat occurrence times according to the IPFM model.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 10943046)

Published in IEEE Trans Biomed Eng on August 01, 2000

Authors

J Mateo1, P Laguna

Author Affiliations

1: Departamento de Ingeniería Electrónica y Comunicaciones, Universidad de Zaragoza, Spain. jmateo@posta.unizar.es

Articles by these authors

Low incidence of factor VIII inhibitors in previously untreated patients during prophylaxis, on-demand treatment and surgical procedures, with Octanate®: interim report from an ongoing prospective clinical study. Haemophilia (2010) 2.05

Photoplethysmography pulse rate variability as a surrogate measurement of heart rate variability during non-stationary conditions. Physiol Meas (2010) 1.28

Alignment methods for averaging of high-resolution cardiac signals: a comparative study of performance. IEEE Trans Biomed Eng (1991) 1.24

Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics. Haemophilia (2013) 1.11

Control group and maintenance treatment with bacillus Calmette-Guerin for carcinoma in situ and/or high grade bladder tumors. J Urol (2001) 1.05

Automatic detection of ST-T complex changes on the ECG using filtered RMS difference series: application to ambulatory ischemia monitoring. IEEE Trans Biomed Eng (2000) 0.99

Vectorcardiographic loop alignment and the measurement of morphologic beat-to-beat variability in noisy signals. IEEE Trans Biomed Eng (2000) 0.92

Correlation between clinical, radiological and ultrasonographical image of knee joints in children with haemophilia. Haemophilia (2001) 0.90

Comparative study of local and Karhunen-Loève-based ST-T indexes in recordings from human subjects with induced myocardial ischemia. Comput Biomed Res (1998) 0.90

Assessment of the dynamic interactions between heart rate and arterial pressure by the cross time-frequency analysis. Physiol Meas (2012) 0.86

The use of mannitol in partial and live donor nephrectomy: an international survey. World J Urol (2012) 0.85

Detection of body position changes using the surface electrocardiogram. Med Biol Eng Comput (2003) 0.84

Modeling and quantification of repolarization feature dependency on heart rate. Methods Inf Med (2014) 0.83

Coronary artery disease diagnosis based on exercise electrocardiogram indexes from repolarisation, depolarisation and heart rate variability. Med Biol Eng Comput (2003) 0.82

Haemothorax in children with congenital coagulopathy. Haemophilia (2010) 0.81

Orthonormal (Fourier and Walsh) models of time-varying evoked potentials in neurological injury. IEEE Trans Biomed Eng (1993) 0.80

Respiration effect on single and multi lead ECG delineation strategies. Conf Proc IEEE Eng Med Biol Soc (2010) 0.80

What is the added value of combined core biopsy and fine needle aspiration in the diagnostic process of renal tumours? World J Urol (2011) 0.80

[Renal hemangiomas: a clinical case and review of the literature]. Actas Urol Esp (1992) 0.79

Single-dose (270 microg kg(-1)) recombinant activated factor VII for the treatment and prevention of bleeds in haemophilia A patients with inhibitors: experience from seven European haemophilia centres. Haemophilia (2009) 0.79

Clinical efficacy, safety and pharmacokinetic properties of the factor VIII concentrate Haemoctin SDH in previously treated patients with severe haemophilia A. Haemophilia (2004) 0.79

Estimation of the respiratory frequency using spatial information in the VCG. Med Eng Phys (2003) 0.79

Grazing collisions of black holes via the excision of singularities. Phys Rev Lett (2000) 0.78

[Posterior leukoencephalopathy reversible syndrome secondary to panarteritis nodosa]. Med Clin (Barc) (1997) 0.78

Pleural effusion in giant cell arteritis. Ann Intern Med (1992) 0.78

Efficacy and safety of OCTANINE F in children with haemophilia B. Haemophilia (2008) 0.77

Head-to-head comparison of the pharmacokinetic profiles of a high-purity factor IX concentrate (AlphaNine®) and a recombinant factor IX (BeneFIX®) in patients with severe haemophilia B. Haemophilia (2013) 0.77

A clinical study assessing the pharmacokinetics, efficacy and safety of AlphaNine(®) , a high-purity factor IX concentrate, in patients with severe haemophilia B. Haemophilia (2011) 0.76

Factor IX pharmacokinetics: differences between plasma-derived and recombinant products and the clinical and economic implications: a meeting report. Haemophilia (2008) 0.76

Clinical efficacy, safety and pharmacokinetic properties of the plasma-derived factor IX concentrate Haemonine in previously treated patients with severe haemophilia B. Haemophilia (2011) 0.76

Histological evaluation of superficial bladder tumors treated by Nd-YAG laser and transurethral resection. Eur Urol (1991) 0.76

[Laparoscopic pelvic surgery: Where do we stand in the year 2006?]. Urologe A (2006) 0.75

Subclavian vein thrombosis in a patient with Raynaud's disease. Postgrad Med J (1994) 0.75

Response to the letter to the editor by Ewenstein BM and Reininger AJ. Haemophilia (2013) 0.75

[Health care management: coordination of health care assistance levels]. Med Clin (Barc) (1996) 0.75

[Colonic adenocarcinoma: its presentation as a fever of unknown origin]. Med Clin (Barc) (1995) 0.75

[Bilateral renal carcinoma]. Actas Urol Esp (1992) 0.75

[Detection of human herpesvirus 8 in patients with Kaposi's sarcoma or Castleman's disease associated with AIDS]. Med Clin (Barc) (1998) 0.75

Successful immune tolerance induction in two boys with haemophilia B and inhibitory antibodies. Haemophilia (2012) 0.75

Evaluation of T-wave alternans activity under stress conditions after 5 d and 21 d of sedentary head-down bed rest. Physiol Meas (2015) 0.75

[Open surgery of calculus of the kidney pelvis. Results and complications in the era of extracorporeal lithotripsy]. Ann Urol (Paris) (1995) 0.75

[A nephrogenic adenoma during treatment with intravesical BCG]. Arch Esp Urol (1992) 0.75

Sleep apnoea detection in children using PPG envelope-based dynamic features. Conf Proc IEEE Eng Med Biol Soc (2011) 0.75

[BCG immunotherapy and vulgar warts]. Actas Urol Esp (1997) 0.75

Assessing real-time RR-QT frequency-domain measures of coupling and causality through inhomogeneous point-process bivariate models. Conf Proc IEEE Eng Med Biol Soc (2014) 0.75

Lymphoscintigraphy for differential diagnosis of peripheral edema: diagnostic yield of different scintigraphic patterns. Rev Esp Med Nucl Imagen Mol (2012) 0.75

[Laser therapy of superficial tumors of the bladder]. Arch Esp Urol (1990) 0.75

[2,8 dihydroxyadenine(2,8 DHA) lithiasis. Report of 3 cases]. Actas Urol Esp (1994) 0.75

Treatment options for distal ureteral stones. Arch Esp Urol (1997) 0.75

[Recombinant hepatitis B vaccine in health personnel. Immunogenicity of a rapid vaccination schedule]. Med Clin (Barc) (1989) 0.75

[Control of the endotracheal cuff balloon pressure as a method of preventing laryngotracheal lesions in critically ill intubated patients]. Rev Esp Anestesiol Reanim (2002) 0.75

[Clinical impact of neoadjuvant treatment to radical prostatectomy in locally advanced prostatic cancer]. Actas Urol Esp (1994) 0.75

Time course of ECG depolarization and repolarization changes during ischemia in PTCA recordings. Methods Inf Med (2004) 0.75

[Orchiopexy]. Arch Esp Urol (1981) 0.75

Automatic measurement of corrected QT interval in Holter recordings: comparison of its dynamic behavior in patients after myocardial infarction with and without life-threatening arrhythmias. Am Heart J (1997) 0.75

In situ transitional cell carcinoma involvement of prostatic urethra: bacillus Calmette-Guérin therapy without previous transurethral resection of the prostate. Urology (1996) 0.75

Prophylaxis in children with haemophilia - the Polish experience. Haemophilia (2013) 0.75

Malignant fibrous histiocytoma of the aorta complicated by anuria. Ann Vasc Surg (1992) 0.75

[Treatment of bladder endometriosis using the Nd-Yag laser]. Arch Esp Urol (1991) 0.75

Identification of the occluded artery in patients with myocardial ischemia induced by prolonged percutaneous transluminal coronary angioplasty using traditional vs transformed ECG-based indexes. Comput Biomed Res (1999) 0.75

Temporal evolution of traditional versus transformed ECG-based indexes in patients with induced myocardial ischemia. J Electrocardiol (2000) 0.75